Yaprak O, Acar S, Ertugrul G, Dayangac M. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World J Gastrointest Oncol 2018; 10(10): 336-343 [PMID: 30364796 DOI: 10.4251/wjgo.v10.i10.336]
Corresponding Author of This Article
Onur Yaprak, MD, Associate Professor, Medipol University Hospital, Center for Organ Transplantation, Goztepe Mah. Metin Sk. No.4, Bagcilar, Istanbul 34214, Turkey. onuryaprak@hotmail.com
Research Domain of This Article
Oncology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Dynamic evaluation (tumor doubling time and change in AFP)[19]
FDG-PET scan
Table 4 The standardized uptake values used to define clinically significant 18F-fluorodeoxyglucose positron emission tomography/computed tomography positivity for hepatocellular carcinoma
Table 5 The use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting post-transplant hepatocellular carcinoma recurrences
Citation: Yaprak O, Acar S, Ertugrul G, Dayangac M. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation. World J Gastrointest Oncol 2018; 10(10): 336-343